Boston Scientific Prevails in U.S. Edwards Lifesciences Litigation
Feature | Heart Valve Technology

A jury in the U.S. District Court for the District of Delaware determined Dec. 11 that the Boston Scientific U.S. patent 8,992,608 is valid and that Edwards Lifesciences' Sapien 3 Aortic Valve infringes this patent. The court ruled that Edwards owes Boston Scientific $35 million in infringement damages through the end of 2016. Additional damages and interest incurred from 2017-2018 will be determined by the court in post-trial motions.

Home December 12, 2018
Home
Videos

This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...

Home December 12, 2018
Home
Videos | Angiography

This is a quick walk around of a GE Healthcare Image Guided System (IGS) angiography system cath lab room display at the ...

Home December 12, 2018
Home
Videos | Cardiovascular Ultrasound

This is an example of the new Fetal HQ heart and vascular software from GE Healthcare for fetal ultrasound. The software ...

Home December 12, 2018
Home
Videos | Stroke

The FDA cleared the MaxQ AI Accipio Ix intracranial hemorrhage (ICH) detection software in November 2018. Here it is ...

Home December 12, 2018
Home
Videos | Artificial Intelligence

This is a quick video tour of the Machine Learning Showcase at the Radiological Society Of North America (RSNA) 2018 ...

Home December 12, 2018
Home
Videos | Cybersecurity

Anton S. Becker, M.D., radiology resident at the University Hospital of Zurich, Switzerland, discusses the long-term ...

Home December 12, 2018
Home
Videos | Advanced Visualization

This is an example of the FDA-cleared OpenSight augmented reality (AR) system for surgical planning from NovaRad at the ...

Home December 12, 2018
Home
Videos | Artificial Intelligence

This is an example of how artificial intelligence (AI) can help improve patient care by pulling together patient data ...

Home December 12, 2018
Home
News | Cardiovascular Surgery

The scientific journal Nature recently published an article from Munich University Hospital which describes the long-term survival of baboons that had received a heart transplant from genetically modified pigs.1 This is an important step forward on the way to being able to give humans porcine heart transplants.

Home December 11, 2018
Home
Blog

There are numerous factors that impact the larger picture in cardiology, especially from a business perspective. Here ...

Home December 11, 2018
Home
News | Pharmaceuticals

December 11, 2018 — Mylan Pharmaceuticals is expanding its consumer-level voluntary nationwide recall to include all ...

Home December 11, 2018
Home
News | EP Lab

December 10, 2018 — Electrophysiology, while currently a relatively small market at $4.6 billion in 2018, has recently ...

Home December 10, 2018
Home
News | Artificial Intelligence

Medical artificial intelligence (AI) company Bay Labs announced a collaboration with Edwards Lifesciences focused on improving the detection of heart disease. The partnership involves multiple initiatives, including the development of new AI-powered algorithms in Bay Labs’ EchoMD measurement and interpretation software suite, the integration of EchoMD algorithms into Edwards Lifesciences’ CardioCare quality care navigation platform, and support for ongoing clinical studies at leading institutions.

Home December 10, 2018
Home
News | Cardiovascular Ultrasound

Hitachi Medical Systems Europe introduced what it calls the next level of intelligent Vector Flow Mapping (iVFM) at EuroEcho Imaging 2018, Dec. 5-8 in Milan, Italy.

Home December 07, 2018
Home
Subscribe Now